Thoracolumbar interfascial plane block better than LA infiltration Dr Monish Raut15 Sep 2022 2:15 PM GMTDue to the substantial dissection and muscle retraction conducted during spine procedures, patients experience acute postoperative discomfort....
Casirivimab/Imdevimab - An Indian Real World Experience : Review Dr. Kamal Kant Kohli10 Jun 2022 6:19 AM GMTThe antibody cocktail (Casirivimab and Imdevimab) has been approved in India for the treatment of mild to moderate COVID-19 in adolescents and adults...
Epidural Volume Extension Technique safe for high risk cardiac patients undergoing LSCS Dr Monish Raut26 May 2022 2:30 PM GMTIn order to increase the height of the sensory block, epidural volume extension includes the infusion of normal saline into the epidural space...
Perioperative optimization enhances COVID-19 mucormycosis results Dr Monish Raut24 May 2022 2:30 PM GMTDelta variants of the coronavirus disease (COVID)-19 pandemic are often linked to rhino-orbital cerebral mucormycosis during the second wave of the...
Review: Efficacy of Antiviral Agents Against Omicron Subvariant BA.2 Dr. Kamal Kant Kohli16 May 2022 6:15 AM GMTThe omicron (B.1.1.529) variant of SARS-CoV-2, has spread rapidly around the world and has already become the predominant variant circulating in many...
Quick Review: Effectiveness of REGEN-COV antibody cocktail against B.1.617.2 (delta) variant of SARS-CoV-2 Dr. Kamal Kant Kohli1 Feb 2022 7:04 AM GMTCasirivimab plus imdevimab antibody cocktail (REGEN-COV) has been shown to reduce viral load and prevent symptomatic disease in household contacts of...
Evaluation of change in perfusion index as indication of effective supraclavicular blockade Dr Monish Raut11 Nov 2021 3:30 AM GMTThe supraclavicular block (SCB) guided by ultrasound is a frequently used peripheral nerve block for anesthesia during upper extremity surgeries. Due...
Weak cough strength associated with increased extubation failure, finds study Dr Monish Raut10 Nov 2021 6:45 AM GMTThe predictive power of extubation failure diagnosed by cough strength varies by study. Researchers have conducted a meta-analysis to summarise the...
Casirivimab-Imdevimab Treatment in Mild to Moderate COVID-19: A Real-World Evidence Dr. Kamal Kant Kohli19 Oct 2021 6:30 AM GMTCasirivimab and Imdevimab are two non-competing, high-affinity human IgG1 anti-SARS- CoV-2 monoclonal antibodies that bind non-competitively to the...
Amoxicillin - A reaffirmed First-Line Therapy in Common Infections Dr. Kamal Kant Kohli10 April 2021 6:32 AM GMTAmoxicillin is one of the most largely experienced, durably utilized antimicrobial agents in primary care settings (1). It remains a valuable choice...
